Latest Announcements

Ramky Infrastructure Ltd has released its investor presentation for the quarter and half year ended September 30, 2026, highlighting its strong execution discipline, excellent margins, and a diversified order book. The company's CEO, Sunil Nair, expressed confidence in delivering on its medium-term growth and long-term profitable aspirations.

State Bank of India held an Analyst Meet following the announcement of its second quarter results. The Chairman, Mr. C.S. Setty, presented an overview of the bank's Q2 FY2027 performance and strategic initiatives undertaken during the period. The bank's financial results reflect the continued resilience of the Indian economy and the underlying strength of SBI's franchise.

Brooks Laboratories Ltd has announced its financial results for the quarter and half year ended September 30, 2026, with a net profit of ₹6,998.82 and ₹7,140.68, respectively. The company's revenue from operations was ₹1,924.79 lakhs and ₹2,296.08 lakhs for the quarter and half year, respectively.

Brooks Laboratories Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company reported a net profit of ₹6,998.82 lakhs for the quarter and ₹7,140.68 lakhs for the half year. The results will be published in the newspapers in due course.

Jaro Education reported a robust H1 FY27 performance with a 21% YoY growth in PAT, 15% YoY growth in Total Income, and 12% YoY growth in EBITDA. The company also witnessed encouraging operational traction with learner volumes registering 7% YoY growth, Average Revenue Per User (ARPU) increasing 5%, and gross bookings growing 13% YoY.

Jaro Education reported robust H1 FY27 performance with 15% YoY growth in Total Income and 21% YoY growth in PAT. Revenue from operations increased 10% YoY to Rs. 8,774 lakh in Q2 FY27. EBITDA grew 7% YoY to Rs. 2,844 lakh, while PAT margin remained healthy at approximately 21% of Revenue from Operations.

Baroda Rayon Corporation Ltd has received a favorable order from the Income Tax Appellate Tribunal, allowing both its quantum and penalty appeals for Assessment Year 2014-15. The Tribunal directed the deletion of an addition of ₹12,15,00,000 made under Section 68 of the Income-tax Act, 1961, and the penalty of ₹4,12,97,850 levied under Section 271(1)(c) of the Act.

Data Patterns (India) Limited has informed the Exchange about Investor Presentation for Q2 FY 2026-27, with a strong outlook and positioning across the portfolio, and a focus on delivering profitable growth and strong cash generation.

Data Patterns (India) Ltd has announced its investor presentation for Q2 FY 2026-27, highlighting its strong order inflow, revenue growth, and EBITDA margins. The company has received fresh orders worth Rs. 929 crore in Q2FY27, taking H1FY27 inflows to Rs. 1,858 crore. The company is confident on growing its existing product profile and expects additional revenue generation by tapping the larger market opportunities from new international customers.

Shelter Pharma Ltd has announced its un-audited financial results for the half year ended September 30, 2026, with revenue up 35.6% to Rs 451.3 million and PAT up 15.4% to Rs 51.9 million. The company's management has discussed its performance, highlighting growth in both human and animal health segments, with domestic sales and exports contributing to the revenue. The gross margin was 22.6%, lower than the previous year due to increased logistics costs. EBITDA rose 17.9% YoY and 14.2% HoH to Rs 73.8 million, with a margin of 16.4%, up 13 bps HoH and down 244 bps YoY.

Shelter Pharma Ltd announced its un-audited standalone financial results for the half year ended September 30, 2026, with revenue up 35.6% to Rs 451.3 million and PAT up 15.4% to Rs 51.9 million. The company reported a gross margin of 22.6%, 237 bps lower YoY and 57 bps lower HoH, due to increased logistics costs. EBITDA rose 17.9% YoY and 14.2% HoH to Rs 73.8 million.

Shringar House of Mangalsutra Ltd has released its Q2 & H1 FY27 earnings conference call transcript, highlighting a strong performance with healthy growth in revenue and profitability. The company has completed one year since its listing on the stock exchanges and has continued to focus on strengthening its business, building customer relationships, and creating a strong foundation for future growth.

Suprajit Engineering Limited has informed the Exchange regarding 'Press Release and Investors Presentation dated November 7, 2026'. The company's overall operating performance was solid, with consolidated revenue growing by 20.6% and EBITDA growing by 26.7% in the quarter. Revenue growth was exceptionally strong at 24.3% at GCM and 50.4% at SED. The company's Global Cables & Mechatronics Division (GCM) delivered strong operational numbers, with revenue growing by 24+% in both the quarter and the half year, and EBITDA growth at 69% for the quarter and 115.9% for the half year.

Shalby Ltd's Q2 FY 2027 earnings conference call transcript reveals a broad-based growth in the Hospitals business, with joint replacement continuing to grow and other specialties like nephrology and urology showing significant growth. The company is expanding its multispecialty network, adding specialist doctors, and improving operational efficiencies. The MedTech business is also expanding its robotic surgery capabilities in oncology and urology.

Suprajit Engineering Limited has announced its quarterly press release and presentation for FY27 Q2, with consolidated revenue growing by 20.6% and EBITDA by 26.7%. The company has reported strong operational numbers, with revenue growth of 24.3% at Global Cables & Mechatronics Division and 50.4% at Specialized Engineering Division. The company has also announced a significant capacity expansion plan by setting up a greenfield cable facility in Chennai.

Tata Chemicals Ltd declared its financial results for Q2FY27, with standalone revenue from operations growing by 8% to ₹ 1,303 Cr and EBITDA growing by 22% to ₹ 292 Cr. Consolidated revenue from operations grew by 8% to ₹ 4,177 Cr and EBITDA at ₹ 381 Cr. The company's consolidated results were impacted by a sharp rise in UK natural gas costs and the temporary suspension of operations in Kenya.

Tata Chemicals Limited has declared its financial results for the quarter and half year ended September 30, 2026, with standalone revenue from operations growing by 8% to ₹ 1,303 Cr and EBITDA growing by 22% to ₹ 292 Cr.

Suprajit Engineering Ltd. has announced its quarterly press release and presentation for FY27 Q2, reporting a 20.6% revenue growth and 26.7% EBITDA growth. The company's overall operating performance was solid, with strong revenue growth in the automotive sector. However, global markets remained subdued due to geopolitical conflicts, inflation, and rising interest rates.

Suprajit Engineering Ltd. announced its quarterly press release and presentation for FY27 Q2, reporting strong revenue and EBITDA growth. The company's Global Cables & Mechatronics Division (GCM) delivered exceptional operational numbers, with revenue growth of 24.3% and EBITDA growth of 69% in the quarter. The Indian automotive sector grew 20.2% due to the lower GST regime, but is expected to temper in the second half due to the high base effect of last year. The company's overall operating performance was solid, with consolidated revenue growing by 20.6% and EBITDA growing by 26.7%.

Shalby Limited has informed the Exchange about Transcript of Earnings Conference Call for Q2 FY2027. The call was held on November 4, 2026, wherein Unaudited Financial Results for Q2 FY 2026-27 were discussed.